Prasanth Kumar

Antibody Engineer | Ex-Enzyme Engineer | Building Automated HTP Methods for Functional Assays & DNA Library Construction at Generate Biomedicines

[Prasanth Kumar @pkumar_39]

@kunjapur @geochurch @WilfredChen1 Congratulations Aditya 🎉

[Prasanth Kumar @pkumar_39]

Impressive work from the @vatsanraman lab on biosensor development 🎉 This platform enables designing biosensors to detect small molecules, with applications like detecting contaminants in water, drug metabolism, and more. Excited to see its real-world impact! #biosensors

[Vatsan Raman @vatsanraman]

Biosensors are a cornerstone of synthetic biology!

Thrilled to share Sensor-seq, a scalable, sequencing-based platform for designing allosteric transcription factors (aTFs) that respond to non-native ligands.

With Sensor-seq, we created aTFs to detect molecules like naltrexone, quinine, and tamoxifen derivatives. This platform opens the door to designing biosensors on demand for new molecules of interest!
https://t.co/jpkrGYApQT

[Rafeeque @rafeequemavoor]

Free scientific illustrations for biologists! 😍

@NIH has released a library of 500+ free scientific illustrations to create figures, presentations, and illustrations!

all freely available in the public domain.

Retweet and spread the message!
https://t.co/p1bD1kxO7H

[Prasanth Kumar @pkumar_39]

@jrkelly I enjoyed learning about your vision for biotech and the importance of collaboration, strategic investment, and policy choices in leading the biotech revolution. Thanks for your leadership and service to the country! #BioTechRevolution

https://t.co/WIpKSkvrUa

[Prasanth Kumar @pkumar_39]

Congrats, @davidrliu and @PrimeMedicine. I'm truly amazed at how quickly you transformed your ideas into life-saving treatments. It's very inspiring!

I'll keep my fingers crossed for the Clinical Trials 🤞

[David R. Liu @davidrliu]

The first prime editing clinical trial has been cleared by @US_FDA to begin: prime editing of HSCs to treat chronic granulomatous disease (CGD). Congratulations to @PrimeMedicine on achieving this key milestone only 4.5 years after we published the first prime editing paper.

[Prasanth Kumar @pkumar_39]

@jrkelly @Ginkgo Thanks for answering my question. I'm looking forward to watching your keynote this weekend!

[Prasanth Kumar @pkumar_39]

@jrkelly @jrkelly Congratulations on expanding the access of @Ginkgo foundry to more researchers. I have a naive question: What do you think differentiates Ginkgo from other CROs that offer similar services?

[Prasanth Kumar @pkumar_39]

@kunjapur @ScienceMagazine @BioCPH @Neil_D_Butler @cfromen Congratulations Aditya 🎉

[Prasanth Kumar @pkumar_39]

@aliceyting Congratulations on this excellent work @aliceyting and team. I have a naive question: If the amount of mcherry in the cells can be measured, does it imply that the rate of degradation is much slower than the rate of internalization?

[Prasanth Kumar @pkumar_39]

@davidrliu Wow... This is a beautiful piece of art. The emotions captured are quite touching!!!

[Prasanth Kumar @pkumar_39]

@liugroup @davidrliu Wish you a happy birthday @davidrliu Super excited for the next game-changing research and therapeutics you are going bring to the world in the next decade 🎉